These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39213787)

  • 1. 5-Hydroxymethylcytosines in circulating cell-free DNA as a diagnostic biomarker for nasopharyngeal carcinoma.
    Chen B; Wang D; Xu Y; Guo Q; Pan J; Yu S; Fang Y; Xiao S; Ruan Y; Yang S; Lin M; Hong J; Zhan Z; Lin S
    Eur J Cancer; 2024 Oct; 210():114294. PubMed ID: 39213787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection.
    Qiu SF; Zhang QZ; Wu ZY; Liu MZ; Ding Q; Sun FM; Wang Y; Yang HX; Zheng L; Chen X; Wu L; Bai J; Liu JF; Chen CB
    EBioMedicine; 2024 Oct; 108():105321. PubMed ID: 39265506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
    Cai J; Chen L; Zhang Z; Zhang X; Lu X; Liu W; Shi G; Ge Y; Gao P; Yang Y; Ke A; Xiao L; Dong R; Zhu Y; Yang X; Wang J; Zhu T; Yang D; Huang X; Sui C; Qiu S; Shen F; Sun H; Zhou W; Zhou J; Nie J; Zeng C; Stroup EK; Zhang X; Chiu BC; Lau WY; He C; Wang H; Zhang W; Fan J
    Gut; 2019 Dec; 68(12):2195-2205. PubMed ID: 31358576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
    Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
    J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study.
    Chang W; Zhang Z; Jia B; Ding K; Pan Z; Su G; Zhang W; Liu T; Zhong Y; He G; Ren L; Wei Y; Li D; Cui X; Yang J; Shi Y; Bissonnette M; He C; Zhang W; Fan J; Xu J
    Clin Cancer Res; 2024 Aug; 30(15):3337-3348. PubMed ID: 38814264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
    Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
    Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
    Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of RERG and ZNF671 methylation rates in circulating cell-free DNA: A novel biomarker for screening of nasopharyngeal carcinoma.
    Xu Y; Zhao W; Mo Y; Ma N; Midorikawa K; Kobayashi H; Hiraku Y; Oikawa S; Zhang Z; Huang G; Takeuchi K; Murata M
    Cancer Sci; 2020 Jul; 111(7):2536-2545. PubMed ID: 32324312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
    Xue N; Lin JH; Xing S; Liu D; Li SB; Lai YZ; Wang XP; Mao MJ; Zhong Q; Zeng MS; Liu WL
    Cancer Res Treat; 2019 Jan; 51(1):378-390. PubMed ID: 29807404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    West-Szymanski DC; Zhang Z; Cui XL; Kowitwanich K; Gao L; Deng Z; Dougherty U; Williams C; Merkle S; He C; Zhang W; Bissonnette M
    JCO Precis Oncol; 2024 Oct; 8():e2400277. PubMed ID: 39393034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
    Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
    Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
    Tan GW; Sivanesan VM; Abdul Rahman FI; Hassan F; Hasbullah HH; Ng CC; Khoo AS; Tan LP
    Int J Cancer; 2019 Oct; 145(8):2260-2266. PubMed ID: 30698824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small extracellular vesicle CA1 as a promising diagnostic biomarker for nasopharyngeal carcinoma.
    Peng M; Zhou Y; Zhang Y; Cong Y; Zhao M; Wang F; Ding T; Liu C; Ni C; Ding J; Sun W; Lyu X; Fan C; Li D; Guo X; Liu X; Li X
    Int J Biol Macromol; 2024 Aug; 275(Pt 1):133403. PubMed ID: 38917926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
    Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
    Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer.
    Cao F; Wei A; Hu X; He Y; Zhang J; Xia L; Tu K; Yuan J; Guo Z; Liu H; Xie D; Li A
    Clin Epigenetics; 2020 Jul; 12(1):112. PubMed ID: 32703318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes.
    Yang Y; Zeng C; Lu X; Song Y; Nie J; Ran R; Zhang Z; He C; Zhang W; Liu SM
    Clin Chem; 2019 Nov; 65(11):1414-1425. PubMed ID: 31575611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
    Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
    Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma.
    Li R; Lu C; Yang W; Zhou Y; Zhong J; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Hu H; Lai Y
    J Clin Lab Anal; 2022 Feb; 36(2):e24194. PubMed ID: 35028969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
    Tay JK; Siow CH; Goh HL; Lim CM; Hsu PP; Chan SH; Loh KS
    Int J Cancer; 2020 May; 146(10):2923-2931. PubMed ID: 31705522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.